Key result
Enhanced Ca2+ release from the ryanodine receptor and free radicals contribute to intracellular muscle dysfunction and muscle weakness in patients with rheumatoid arthritis.
This review highlights that intracellular muscle dysfunction, driven by enhanced Ca2+ release and free radicals, plays a key role in RA-associated muscle weakness.
Answers are grounded in this paper and cite their sources.
Muscle weakness substantially burdens RA patients; leaves open mechanisms and interventions for prospective study.
In addition to the primary symptoms arising from inflammatory processes in the joints, muscle weakness is commonly reported by patients with rheumatoid arthritis (RA). Muscle weakness not only reduces the quality of life for the affected patients, but also dramatically increases the burden on society since patients' work ability decreases. A 25–70% reduction in muscular strength has been observed in pateints with RA when compared with age-matched healthy controls. The reduction in muscle strength is often larger than what could be explained by the reduction in muscle size in patients with RA, which indicates that intracellular (intrinsic) muscle dysfunction plays an important role in the underlying mechanism of muscle weakness associated with RA. In this review, we highlight the present understanding of RA-associated muscle weakness with special focus on how enhanced Ca 2+ release from the ryanodine receptor and free radicals (reactive oxygen/nitrogen species) contributes to muscle weakness, and recent developments of novel therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2017) conducted a review in Rheumatoid arthritis. Enhanced Ca 2+ release and free radicals was evaluated on Muscle weakness. Enhanced Ca2+ release from the ryanodine receptor and free radicals contribute to intracellular muscle dysfunction and muscle weakness in patients with rheumatoid arthritis.
Synapse has enriched 10 related papers. Consider them for comparative context: